Pactiv Evergreen Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Portfolio Pulse from Benzinga Insights
Pactiv Evergreen (NASDAQ:PTVE) has received 4 analyst ratings in the last three months, with a positive shift in sentiment and an increased average 12-month price target of $16.00, up 37.1% from the previous $11.67. Analysts from UBS, Citigroup, B of A Securities, and RBC Capital have raised their price targets, reflecting optimism about the company's performance. Despite challenges in revenue growth and net margin, Pactiv Evergreen's ROE and ROA outperform industry benchmarks, and its conservative debt management is noted.
January 16, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have raised their price targets for Pactiv Evergreen, indicating a bullish outlook. The average price target has increased to $16.00, with a high estimate of $19.00 and a low of $13.00. The company's strong ROE and ROA are positive, but it faces challenges in revenue growth and net margin.
The increase in the average price target by analysts suggests a positive outlook for PTVE's stock price in the short term. The positive adjustments in ratings and price targets by reputable firms such as UBS, Citigroup, B of A Securities, and RBC Capital are likely to instill investor confidence and could lead to a short-term price increase. However, the challenges in revenue growth and net margin may temper the extent of the positive impact.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100